Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Community-acquired infections
MeSH D017714 - community-acquired infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007239:
Infections
2 Companies
2 Drugs
$
Success rate
D017714:
Community-acquired infections
15 Companies
8 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Pfizer
Ceftaroline fosamil
Zinforo
2012-08-22
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
7/7
Phase 3
33
%
8/24
Approved:
7
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Menarini
Delafloxacin
,
Delafloxacin meglumine
Merck & Co
Ertapenem
Nabriva Therapeutics
Lefamulin
Pfizer
Ceftaroline fosamil
,
Etrolizumab
,
Sodium chloride
,
Bevifimod
,
Lactams
Sanofi
Telithromycin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use